Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study

ClinicalTrials.gov ID: NCT03373968

Public ClinicalTrials.gov record NCT03373968. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 30, 2026, 6:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open Label, Long-term Safety, Tolerability, and Efficacy Study of GIVINOSTAT in All DMD Patients Who Have Been Previously Treated in One of the GIVINOSTAT Studies

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open label, long-term safety, tolerability, and efficacy study of GIVINOSTAT in all DMD (Duchenne's muscular dystrophy) patients who have been previously treated in one of the GIVINOSTAT studies.

Study identification

NCT ID: NCT03373968
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2, Phase 3
Lead sponsor: Italfarmaco; Industry
Enrollment: 206 participants

Conditions and interventions

Conditions

Duchenne Muscular Dystrophy

Interventions

Givinostat Drug

Drug

Eligibility (public fields only)

Age range: 7 Years and older
Sex: Male
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 23, 2017
Primary completion: Nov 30, 2029
Completion: Nov 30, 2029
Last update posted: Jan 20, 2026

2017 – 2029

United States locations

U.S. sites: 10
U.S. states: 9
U.S. cities: 10

Facility	City	State	ZIP	Site status
University of California - Davis Medical Center - Devis Physical Medicine & Rehabilitation	Sacramento	California	95817	Completed
Rady Children's Hospital center - UCSD Department of Neuroscience	San Diego	California	92123	Completed
Connecticut Children's Medical Center, Neurology Division	Hartford	Connecticut	06106	Completed
Child Health Research Institute	Gainesville	Florida	32610	Completed
MD Rare Disease Research, LLC	Atlanta	Georgia	30318	Enrolling by invitation
University of Iowa Children's Hospital	Iowa City	Iowa	52242	Enrolling by invitation
Washington University School of Medicine in St Louis Department of Neurology 660 S.Euclid Avenue, Campus Box 8111	St Louis	Missouri	63110	Completed
Shriners Hospitals for Children	Portland	Oregon	97239	Completed
The Children's Hospital of Philadelphia Colket Translational Research Building	Philadelphia	Pennsylvania	19104	Completed
Virginia Commonwealth University Childrens Hospital of Richmond at	Richmond	Virginia	23298	Completed

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03373968, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 20, 2026 · Synced Jul 30, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03373968 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →